pubmed-article:18628471 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0929301 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0014939 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0014898 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0596263 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
pubmed-article:18628471 | lifeskim:mentions | umls-concept:C0300767 | lld:lifeskim |
pubmed-article:18628471 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:18628471 | pubmed:dateCreated | 2008-7-16 | lld:pubmed |
pubmed-article:18628471 | pubmed:abstractText | To test whether the triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester (CDDO-Me) and the rexinoid LG100268 (268) prevent the formation of estrogen receptor (ER)-negative mammary tumors or either arrest the growth or cause regression of established tumors in MMTV-neu mice. | lld:pubmed |
pubmed-article:18628471 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:language | eng | lld:pubmed |
pubmed-article:18628471 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18628471 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18628471 | pubmed:month | Jul | lld:pubmed |
pubmed-article:18628471 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:HondaTadashiT | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:SpornMichael... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:AlbiniAdriana... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:GribbleGordon... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:LamphWilliam... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:LibyKarenK | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:WilliamsCharl... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:RisingsongRen... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:YoreMark MMM | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:VanniniNicola... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:RoyceDarlene... | lld:pubmed |
pubmed-article:18628471 | pubmed:author | pubmed-author:SognoIlariaI | lld:pubmed |
pubmed-article:18628471 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18628471 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18628471 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:18628471 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18628471 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18628471 | pubmed:pagination | 4556-63 | lld:pubmed |
pubmed-article:18628471 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:meshHeading | pubmed-meshheading:18628471... | lld:pubmed |
pubmed-article:18628471 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18628471 | pubmed:articleTitle | Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268. | lld:pubmed |
pubmed-article:18628471 | pubmed:affiliation | Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03755, USA. karen.liby@darthmouth.edu | lld:pubmed |
pubmed-article:18628471 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18628471 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18628471 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18628471 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18628471 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18628471 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18628471 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18628471 | lld:pubmed |